Arcapita’s CEO: We Have Successfully Executed 100 Investment Transactions with a Total Value of $31 Billion

Arcapita CEO Atif Abdulmalik. (Asharq Al-Awsat)
Arcapita CEO Atif Abdulmalik. (Asharq Al-Awsat)
TT

Arcapita’s CEO: We Have Successfully Executed 100 Investment Transactions with a Total Value of $31 Billion

Arcapita CEO Atif Abdulmalik. (Asharq Al-Awsat)
Arcapita CEO Atif Abdulmalik. (Asharq Al-Awsat)

Atif Abdulmalik, Chief Executive Officer of Arcapita Group Holdings (Arcapita), a Sharia compliant global alternative investment firm, has set out Arcapita’s strategic transformation plan for the coming five years. The strategy aims to increase the size and volume of Arcapita’s transactions in the private equity and real estate sectors by introducing new product offerings. This new phase of expansion builds on Arcapita’s track record of 100 transactions with a total value of US$31 billion over the past 25 years.

Abdulmalik explains that Arcapita’s business activity is a mix of direct private equity investments and investments in real estate with a particular emphasis on industrial properties in the Company’s core markets of the Gulf Cooperation Council (GCC), mainly in Saudi Arabia and the United Arab Emirates, and the US. Through its transformation strategy, Arcapita intends to diversify its asset base further and minimize risk exposure by acquiring real estate and private equity assets in sectors that demonstrate solid long-term fundamentals.

Abdulmalik added that Arcapita is expanding its logistics activities in the Kingdom of Saudi Arabia by creating a logistics-focused real estate fund with investments of up to US$1 billion. Combined with other funds in Saudi Arabia and the UAE, this will bring the Company’s total investments in the industrial sector to US$1.6 billion.

These investments reflect growing demand among foreign and institutional investors for attractive investments in the Saudi market, with much opportunity for growth being driven by Vision 2030 and changing investment approaches by a new generation of investors.

Arcapita has been investing for the past 25 years. What are your plans for the Company’s next phase?

Over the past 25 years, Arcapita has completed 100 investments with a total value of US$31 billion. For our next phase, we have adopted a five-year transformation plan based around making further quality investments in promising markets, increasing the size of our transactions in private equity and real estate, and introducing new product offerings. We are also looking to consolidate our presence in important strategic markets, including opening our offices in Riyadh in April. This new office is an important milestone in furthering our business in the region and will help us capitalize on the opportunities generated by Saudi Vision 2030.

What are the goals of Arcapita’s strategic transformation plan?

Arcapita’s investment strategy focuses on private equity and real estate and with the transformation plan we will increase our activities in both sectors. In terms of real estate, Arcapita intends to diversify its asset base and minimize risk exposure by targeting assets in defensive real estate sectors with strong long-term fundamentals such as the industrial sector and the long-term residential rentals market. In private equity, we look to acquire asset-light technology-enabled companies that have the potential to growth organically and through bolt-on acquisitions.

In addition, Arcapita supports socially responsible investments with select product and service offerings, including deal by deal investments, investment funds and managed accounts. Arcapita also aligns its interests with the interests of its investors by seeking to co-invest a 5% to 10% stake in each investment opportunity.

What are Arcapita’s main investment segments in the private equity sector?

Private equity investments have been a mainstay of Arcapita’s investment strategy over the past two decades. In this space we largely focus on acquisitions in the business services, logistics, and consumer segments, each of which has its own characteristics, growth potential, and return profile.

The outsourced business services sector has considerable growth potential and Arcapita is acquiring companies in areas such as waste management and property valuation. For example, we recently acquired Nationwide, which provides valuation services to large mortgage institutions throughout the United States. Logistics companies and consumer services are also benefiting from the growth of e-commerce, last mile delivery services, and tech-enabled retail; trends which were accelerated by the COVID-19 pandemic.

What about Arcapita’s real estate investments?

Arcapita’s real estate investment strategy focuses on the industrial, multifamily, and student housing sectors.

In the industrial space, we focus on properties that are either leased to a single long-term tenant, or leased to a variety of smaller tenants on shorter term leases. The sector has proven resilient and has historically maintained high occupancy rates during recessionary periods given the vital importance of storage and distribution facilities in supply chains. This was clearly demonstrated during the COVID-19 pandemic as the demand for industrial space was boosted by e-commerce activity. In general, the industrial sector outperformed the office, retail, and hospitality sectors during the pandemic.

Within the multifamily sector, Arcapita strategically invests in markets with strong employment and population growth rates, and concentrates on Class B properties with a selection of Class A properties.

In student housing, we seek properties serving large US public universities with over 10,000 students and located relatively close to campus. Arcapita recently exited the University of Tennessee’s Quarry Trail student housing property after maintaining an occupancy rate of almost 100% despite challenges presented by the pandemic and growing net operating income by approximately 24% over a two year holding period.

Does this expansion in global markets support Sharia compliant products?

As you know, Arcapita has been committed since its inception in 1997 to providing Sharia compliant investment services and products. The key values and ethical standards we have adopted are reflected in all our transactions and activities to date, and that will not change.

We opened our first international office in Atlanta, Georgia in 1998, when Arcapita was the first Sharia compliant private equity investment firm in the United States. Since then, we have witnessed growing global demand for Sharia compliant products, particularly in key international markets where we are now focusing our expansion plans.

Reports show increasing growth in many sectors in the US market. What is the size of Arcapita’s private equity investments in the United States?

Arcapita has invested more than US$17 billion in US private equity and $13 billion in US real estate over the past 25 years, including in some landmark transactions.

For example, one success story was our relationship with Caribou Coffee, the global coffee chain. After acquiring and growing the business, Arcapita took the company public, making it the first Sharia compliant listing on a US exchange. We also partnered with Prologis, a leader in US logistics real estate, and jointly acquired approximately 80 industrial real estate properties across the country and successfully exited that investment in 2006.

We have built a track record of investing in business services companies, and currently have a substantial controlling interest in a number of asset-light US companies. One such example is Nationwide Property and Appraisal Service, the second largest independent appraisal management company in the US, which serves mortgage lending institutions across all 50 states. Nationwide is a market leader with a network of over 15,000 licensed appraisers, with its clients including more than 100 blue-chip lenders and 21 of the top 25 wholesale lenders in the US. This investment is a continuation of Arcapita’s US private equity strategy focused on asset-light, tech-enabled business services companies.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.